The 52nd Union World Conference On Lung Health

19 - 22 October 2021

If you are a Speaker, Presenter or Chair at the 52 nd Union World Conference on Lung Health, please do visit Information for Speakers where you can view webinars to guide you through our virtual platform this year.

Dr Tedros Adhanom Ghebreyesus


Executive Director, WHO

Plenary: Its not fair and its not right: Equity in global health

20 October, 14:00 - 15:00 CEST

Dr Tedros Adhanom Ghebreyesus was elected WHO Director-General for a five-year term by WHO Member States at the Seventieth World Health Assembly in May 2017. In doing so, he was the first WHO Director-General elected from among multiple candidates by the World Health Assembly and was the first person from the WHO African Region to head the world’s leading public health agency. Dr Ghebreyesus served in Ethiopia’s federal government for over a decade as Minister of Health and Minister of Foreign Affairs. He led a comprehensive reform of the country’s health system, built on the foundation of universal health coverage and provision of services to all people, even in the most remote areas.

Naomi Wanjiru


MDR-TB Survivor and Nurse

Speaker at Opening Ceremony

19 October, 10:40 – 11:00 CEST

Naomi Wanjiru is a nurse who worked in a TB and HIV clinic in Kenya. Ms Wanjiru developed lower back pain and after months of consultations, extreme pain and misdiagnosis, scans finally revealed that Naomi had extrapulmonary MDR-TB in her spine. Naomi battled TB stigma through her treatment and was forced to inject herself with TB drugs as nobody was willing to come near her for the fear of contracting TB. Today, Ms Wanjiru is a strong TB

Dr David Baker


Director, Institute for Protein Design

TBScience late-breaker session

21 October 12:00 - 13:30 CEST

Dr David Baker’s research group is focused on the design of macromolecular structures and functions. He received his Ph.D. in biochemistry at the University of California, Berkeley, and did postdoctoral work in biophysics at UCSF. He is also a Howard Hughes Medical Institute Investigator, the Henrietta and Aubrey Davis Endowed Professor in Biochemistry, and an adjunct professor of genome sciences, bioengineering, chemical engineering, computer science, and physics at the University of Washington. Dr Baker is a member of the National Academy of Sciences and the American Academy of Arts and Sciences. He is also a project leader with The Audacious Project.

Dr Robin Wood


Director, Desmond Tutu Health Foundation, South Africa

TBScience Session: Bioaerosols - Threats and opportunities

21 October, 15:00 - 16:35 CEST

Dr Robin Wood is an Emeritus Professor of Medicine at the University of Cape Town and director of the Desmond Tutu Health Foundation which is situated at the Institute of Infectious Disease and Molecular Medicine, UCT. Dr Wood is a pioneer in the introduction of treatment and clinical care of people living with HIV and AIDS in South Africa and was strongly aligned with civil society activists fighting for access to antiretroviral therapy in South Africa. His earlier research was in the interactions between HIV infection and tuberculosis and currently focuses on tuberculosis transmission and disease control.

Dr Jamilah Meghji


Clinical Academic, Liverpool School of Tropical Medicine; Respiratory Registrar at Imperial College in London

Plenary Session: Health and wellbeing post-TB, Covid-19 and other major lung insults

19 October, 14:00 - 15:00 CEST

Dr Jamilah Meghji is a clinical academic with an interest in respiratory health in resource poor settings. Dr Meghji undertook her preclinical medical training at the University of Cambridge, before completing her clinical medical training at Oxford University Medical School. She established a cohort of HIV-infected and uninfected adults completing treatment for pulmonary tuberculosis in urban Malawi, in order to investigate the prevalence, pattern and long-term impacts of residual post-TB lung damage on adults. Dr Meghji is developing a specialist clinical interest in chronic respiratory infection, and her research work remains focused on improving outcomes for TB survivors with residual lung damage.

Dr Seth Berkley


CEO, GAVI, The Vaccine Alliance

Special Session: From 100 years to 100 days: Accelerating the TB vaccine pipeline

20 October at 15:00 - 16:30 CEST

A pioneer in global public health for more than 35 years, Dr Seth Berkley has been a champion of equitable access to vaccines and of innovation and a driving force to improve the way the world prevents and responds to infectious disease. A medical doctor and infectious disease epidemiologist, Dr Berkley joined Gavi, the Vaccine Alliance as its CEO in August 2011. Under his leadership, Gavi has accelerated global immunisation access in its mission to save lives, reduce poverty and protect the world against the threat of epidemics and pandemics.

Dr Debra Hanna


Senior Program Officer in the TB Drug team, Global Health division at the Bill & Melinda Gates Foundation

TBScience: New designs for TB treatment trials: further perspectives

20 October 17:15 - 18 - 35 CEST

Dr Debra Hanna oversees a diverse grant portfolio focused on improved translational science to inform TB drug regimen selection and development, biomarker assessment and validation as well as TB clinical drug development studies in her work at the Bill & Melinda Gates Foundation. She is also a leader within the Project to Accelerate Novel Treatments for TB (PAN-TB) collaboration. She previously served as the Executive Director of the Critical Path to TB Drug Regimens initiative -- a global, multi-sector partnership focused on delivering a tuberculosis data collaboration initiative and multiple program teams focused on accelerating the development of novel drug regimens and rapid drug susceptibility tests for TB.

Dr Kate O'Brien


Director of the Immunization, Vaccines and Biologicals Department, World Health Organization

TBScience session: From basic sciences to implementation - Designing a TB vaccine with the end in mind

22 October at 17:25 – 18:10 CEST

Dr Kate O’Brien is responsible for leading the overall work and strategy of the Immunization, Vaccines and Biologicals Department at the World Health Organization to advance the vision of a world where everyone, everywhere, at every age, fully benefits from vaccines for good health and wellbeing. Prior to joining WHO, she was Professor of International Health and Epidemiology and Executive Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. Her research and policy work focused on vaccine preventable illnesses, especially for pneumonia causing pathogens including pneumococcal disease; Haemophilus influenzae type b; respiratory syncytial virus and influenza.

Dr Robert (Bob) Seder


Chief of the Cellular Immunology Section in the Vaccine Research Center, NIAID, NIH

TBScience Session: TB vaccines: aspiring is not enough!

22 October 15:00 - 16:30 CEST

Dr Robert (Bob) Seder is Chief of the Cellular Immunology Section in the Vaccine Research Center, NIAID, NIH. Dr Seder’s work has focused on the cellular and molecular mechanisms by which vaccines mediate protective immunity in animal models of HIV, malaria, tuberculosis and cancer. More recently, Dr Seder has focused his efforts on discovery of monoclonal antibodies to prevent malaria infection. He has successfully translated his scientific discoveries with “first in human” clinical trials using intravenous vaccination to generate protective immunity with an attenuated malaria vaccine and more recently showing that a monoclonal antibody can prevent malaria infection following controlled challenge.

Dr Michael Hughes


Professor of Biostatistics at Harvard T.H. Chan School of Public Health, Director of the Center for Biostatistics in AIDS Research

TBScience Session: New designs for TB treatment trials - Taking a fresh start

20 October, 15:00 - 16:20 CEST

Dr Michael Hughes is the Principal Investigator of the Statistical and Data Management Center (SDMC) of the AIDS Clinical Trials Group (ACTG). The ACTG undertakes numerous studies of interventions for the treatment of people infected with HIV, including co- infections such as tuberculosis and hepatitis B and C. He was previously Principal Investigator for the SDMC of the Pediatric ACTG and has ongoing HIV research interests in the treatment of children infected with HIV, and the prevention of mother-to-child transmission of HIV. Ongoing research interests include the design and analysis of phase I/II clinical trials, and of bridging trials from one population to another population.

Dr Zanetor Agyeman-Rawlings


Member of Parliament, Doctor, Activist & Campaigner

Plenary Session: One Health - Solutions for a new era

21 October, 14:00-15:00

Dr Zanetor Agyeman-Rawlings is currently a Member of Parliament for the Klottey-Korle Constituency in the Republic of Ghana, serving as a member of the Opposition for the National Democratic Congress Party. Dr Zanetor is currently the deputy ranking member on the committee on defence and interior.

Hon Justice Professor Dingake


Judge in the Seychelles Court of Appeal; President of the Africa Regional Judges Forum on HIV/TB

Plenary Session: It's not fair and it's not right - Equity in global health

20 October, 14:00 - 15:00 CEST

Judge Dingake has been recognised as an exceptional and distinguished scholar by a number of Universities around the globe, including the University of Pretoria, Cape Town and James Cook University in Australia. He is a Honorary Professor of Public Law at the University of Cape Town and Adjunct Professor of Law at James Cook University, Australia. He is a lead facilitator at the Judicial Institute for Africa, (JIFA) UCT, Cape Town, South Africa.

Dr Sunita Narain


Director General, Centre for Science and Environment (CSE), India

Plenary Session: Fighting for air - The air we breathe cannot be taken for granted"

22 October, 14:00 - 15:00 CEST

Dr Narain is an Indian environmentalist and political activist as well as a major proponent of the Green concept of sustainable development. She is a former member of the Prime Minister’s Council for Climate Change and a recipient of the Padma Shri by the Government of India as well as the World Water Prize. Dr Narain has introduced solutions for combating air pollution by leading efforts to implement the use of Compressed Natural Gas to fuel buses in New Delhi, which has become a model for reducing air contamination in transportation.

Dr Tereza Kasaeva


Director, Global TB Programme, World Health Organization


19 October, 15:00 - 16:25 CEST

Dr Tereza Kasaeva is the Director of the World Health Organization’s Global TB Programme. She is responsible for setting norms, policies and standards on global TB prevention, control and care including tackling drug resistance, coordinating technical support, monitoring the global situation, developing innovative interventions through translation of new evidence into policies & practice, promoting research & development and through addressing system challenges such as community and private sector engagement.

Howard Catton


CEO, International Council of Nurses


22 October 15:00 - 16:30 CEST

Howard Catoon is the Chief Executive Officer of the International Council of Nurses (ICN) and is committed to ensure that ICN effectively represents nursing worldwide, advances the nursing profession, promotes the wellbeing of nurses and advocates for health in all policies. He firmly believes that nurses should be at the heart of health policy decision making and leading healthcare systems and delivery.

Dr Pakishe Aaron Motsoaledi


Minister of Internal Affairs, Former Minister of Health, South Africa


22 October 17:25 - 18:10 CEST

Dr Pakishe Aaron Motsoaledi is the current Minister of Home Affairs in South Africa. He previously served as the Minister of Health and holds a Bachelor of Medicine and Surgery from the University of Natal. Prior to his appointment as Minister of Health, Dr Motsoaledi was member of the Limpopo Provincial Legislature from 1994 to 2009 where he held such positions as MEC for Education, Transport and Agriculture.

Dr Soumya Swaminathan


Chief Scientist at the World Health Organization

Speaker at Opening Ceremony

22 October 17:25 - 18:10 CEST

Dr Soumya Swaminathan is the Chief Scientist at the World Health Organization, after serving as the Deputy Director-General of Programmes. A paediatrician from India and a globally recognized researcher on tuberculosis and HIV, she brings with her 30 years of experience in clinical care and research and has worked throughout her career to translate research into impactful programmes. Dr Swaminathan was Secretary to the Government of India for Health Research and Director General of the Indian Council of Medical Research from 2015 to 2017.

Nick Herbert


Member of the House of Lords

Special Session: Can we end TB by 2030?

19 October, 15:00 - 16:25 CEST

Nick Herbert (Lord Herbert of South Downs) is a Member of the House of Lords and the Prime Minister’s Special Envoy on LGBT Rights. He is Chair of the College of Policing, the Countryside Alliance, The Project for Modern Democracy, the Global TB Caucus and the Global Equality Caucus, and he is Board Advisor to Get Licensed.